| Tag | Content |
|---|
EnhancerAtlas ID | HS141-08111 |
Organism | Homo sapiens |
Tissue/cell | NB4 |
Coordinate | chr17:44216760-44218490 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr17:44217200-44217218 | GGAAGGAATGAAGGGAAA | + | 6.35 | | NFAT5 | MA0606.1 | chr17:44216778-44216788 | ATTTTCCATT | + | 6.02 | | NFATC1 | MA0624.1 | chr17:44216778-44216788 | ATTTTCCATT | + | 6.02 | | NFATC3 | MA0625.1 | chr17:44216778-44216788 | ATTTTCCATT | + | 6.02 | | SPI1 | MA0080.4 | chr17:44217193-44217207 | AAAAAGAGGAAGGA | + | 6.06 | | SPIC | MA0687.1 | chr17:44217193-44217207 | AAAAAGAGGAAGGA | + | 6.38 | | ZNF263 | MA0528.1 | chr17:44217231-44217252 | AAAGGAGAGAGGGAAGGGAAA | + | 6.17 |
|
| | Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
| SE_09447 | chr17:44211844-44220714 | CD14 | | SE_11745 | chr17:44215263-44217958 | CD20 | | SE_11745 | chr17:44218061-44220245 | CD20 | | SE_13432 | chr17:44215536-44217687 | CD34_Primary_RO01536 | | SE_18395 | chr17:44212896-44219276 | CD4p_CD25-_Il17-_PMAstim_Th |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 3 | Chromosome | Start | End |
| chr17 | 44216778 | 44217184 | | chr17 | 44218132 | 44218182 | | chr17 | 44217237 | 44217310 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH17I046137 | chr17 | 44215181 | 44217566 |
|
Enhancer Sequence | CTCAAGGTGA AGTTACTCAT TTTCCATTAT TTCTCTCTAA CATCAATTTC TCCACCAGAT 60
TTCCTCCACC TGTGCCACTA CTCACCCATC TAAATGTGCA CATGTGTACT CAAGCATTCA 120
ATGAATTGCT TATTATGTAC TACTCAGCAC GAAGAAGCAG AGGAAACCCA GCCTTTGGAG 180
TGATATGAAC CTGACTCTAC TTCTTGTTTT AACCAATTAC TAAGCCTTGT GACCTCGGGA 240
AGTCAATCAT TATGTCTAGT ACTCCTGTTG CCTAACTGTA AAAATGTGAA GGATTATTAC 300
GTACATAAAA GCATAATACC AAAAATAGGC ACTAACTGAT TGTTAGTTTC CGTCCCTCTC 360
CTACAACAGC ACCCTGACTT TGGAAACTAA CCCTCCACGA ACTGAAAGCA TTCTCAGAAT 420
ATACTGTCCT TAAAAAAAGA GGAAGGAATG AAGGGAAAGA AAAGAAAAGA AAAAGGAGAG 480
AGGGAAGGGA AAAGGCAAAA ATTTTTAAAA ATACTTTTGG TCCTGGTTTA CAGGCCACCA 540
CAATAATTCA AGTAAATTAG CATAATCCAG AGAGACAAAA ACTTTTTCTA TTTTTTACTA 600
CACCAAAAAA GCTCATAATA AAATTTCAAA GTATTAAAAA ATAAATGAAA GTAATCCCTT 660
CCCTTCCTCC ATCCCAACCC ATCCCATCCC TCAGAAATAA TCACTGTTAG CACTCTGGTG 720
TGCACATATA CACATACACA TACATACATA TATATTTTTG TTGCCAAAAT TTTACTGCAG 780
ATATCTGGAA AATAAAGAGT AGCATAAAGA AGAAAAATAT GTAATCTATA CAACCGGAAA 840
AAATTTTAAG CTGCAAATAA GTTTCCACAA CTAAATTTAC ATTGTAAAAC ACATGATGGG 900
GAAAAAAAGG TCTTTACAAT AAATATGGTA CAAGGACAAC TGAATATCCA CTATCCACAG 960
GCAAAATAAA ATTGGATTCC TACCTCACAC CATACAGAAA ACTAACTTAA AGTCGATCAA 1020
AGCCCTACTT AAATGTAAGC ATTGAAACTC CTGGAAAAAA GCATAGGAGT AAATTCTTCA 1080
TGAACTTGGG TTAGGCAATG ATTTCTTATG CTGTGACACA AAAAGCAAAA GAAACAAAAA 1140
AAAAACATAA ATTGGACTAT ATCAAAATTT AAAACTTCTG TAAATAATAA TCAAGAAAAT 1200
GAGAATACAA TCCACAGAAT GGAAGAAAAT ATCTGAAAAT CATCTATTTG ACAAGACACT 1260
GGTCTCCAGA ATATATACAA AAAACACAAT TCAACAATTT TTAAAAACCA AATAACTTTA 1320
GAAATGAGCA AAGGATCTCC AAAGAAGATA TACAAATGAC CAATTAAGCA CCTGAAACGA 1380
TTATCAGCAT CATTAGCCAT TAGAGAAATT AAAATCAAAA CCACAATGAG ATACCACTTC 1440
ACATTGACTA GCATGGCTAT AATTAAAAAG ACAATTAGAA GCATTGGCAA GAATGTGGAG 1500
AGAATGGAAC CCACAAATAT CGCTCATGGT AATACAAAAT GGTAATATAA AATGGAAAAC 1560
AGGCAGTTCC TCAAAAAGTT ATACACAGGG CTACTTTATG TGTTAAATGC TGAGGATGCA 1620
TAAAGGATCA GAAATTCAGA TAAAGCATTC CCAGAACAGT GATTGATCCT GTTTGTTTAA 1680
AAAAAAAAAA AGACAATGTA CTCAACAATT AACTAAAGTA CTTGTATTTC 1730
|
